ID

16732

Description

Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193167

Link

https://clinicaltrials.gov/show/NCT00193167

Keywords

  1. 8/3/16 8/3/16 -
Uploaded on

August 3, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Colon Cancer NCT00193167

Eligibility Colon Cancer NCT00193167

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
to be included in this study, you must meet the following criteria:
Description

criteria Fulfill

Data type

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1550543
metastatic colorectal cancer
Description

Colorectal cancer metastatic

Data type

boolean

Alias
UMLS CUI [1]
C0948380
one previous chemotherapy for metastatic disease
Description

Prior Chemotherapy Quantity Neoplasm Metastasis

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
measurable or evaluable disease
Description

Measurable Disease | Evaluable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
able to perform activities of daily living with assistance
Description

Performance of activities of daily living Assisted Ability

Data type

boolean

Alias
UMLS CUI [1,1]
C1821398
UMLS CUI [1,2]
C1269765
UMLS CUI [1,3]
C0085732
adequate bone marrow, liver, and kidney function
Description

Bone Marrow function | Liver function | Renal function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
all patients must give written informed consent prior to study entry.
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
you cannot participate in this study if any of the following apply to you:
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
brain or meningeal involvement
Description

Brain Involvement | Meninges Involvement

Data type

boolean

Alias
UMLS CUI [1,1]
C0006104
UMLS CUI [1,2]
C1314939
UMLS CUI [2,1]
C0025285
UMLS CUI [2,2]
C1314939
serious active infection or underlying medical conditions
Description

Communicable Diseases Serious | medical condition Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205404
other active neoplasms are ineligible
Description

Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0027651
pregnant or lactating
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Colon Cancer NCT00193167

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
criteria Fulfill
Item
to be included in this study, you must meet the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Colorectal cancer metastatic
Item
metastatic colorectal cancer
boolean
C0948380 (UMLS CUI [1])
Prior Chemotherapy Quantity Neoplasm Metastasis
Item
one previous chemotherapy for metastatic disease
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
Performance of activities of daily living Assisted Ability
Item
able to perform activities of daily living with assistance
boolean
C1821398 (UMLS CUI [1,1])
C1269765 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver, and kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Informed consent
Item
all patients must give written informed consent prior to study entry.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
you cannot participate in this study if any of the following apply to you:
boolean
C2348568 (UMLS CUI [1])
Brain Involvement | Meninges Involvement
Item
brain or meningeal involvement
boolean
C0006104 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0025285 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
Communicable Diseases Serious | medical condition Serious
Item
serious active infection or underlying medical conditions
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
Neoplasms
Item
other active neoplasms are ineligible
boolean
C0027651 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C2348568 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial